For in vitro diagnostic use. Others BARB IVD BARB CPS_000045 ONLINE DAT Barbiturates Plus 20737976122 COBAS INTEGRA BARBITURATES 200 BARB 04015630993468 Reagents, kits 2053365122 200 tests COBAS INTEGRA 400 Plus true 06344470190 BARB 100Tests cobas c 701,702 BARB 04015630930418 Reagents, kits 100 tests cobas c 701/702 true 04490754190 BARB, 200T, cobas c BARB 04015630998869 Reagents, kits 200 tests cobas c 311/501/502 true 08056889190 BARB, 850T, cobas c pack green BARB 07613336121030 Reagents, kits 850 tests cobas c 303/503/703 true 0220737976122COIN BARB Abuscreen OnLine Barbiturates en 8 FF0000000595CB0E FF0000000595CB0E 20737976122 302 COBAS INTEGRA 400 plus Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useBarbiturates (BARB) is an in vitro diagnostic test for the semiquantitative and qualitative detection of barbiturates in human urine at a cutoff concentration of 200 ng/mL on COBAS INTEGRA systems.Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC/MS). Barbiturates provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC/MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998.Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 06344470500 BARB ONLINE DAT Barbiturates Plus en 6 FF00000006A9C30E FF00000000173B0E 06344470190 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useBarbiturates Plus (BARB) is an in vitro diagnostic test for the qualitative and semiquantitative detection of barbiturates in human urine on cobas c systems at a cutoff concentration of 200 ng/mL. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC‑MS). Barbiturates Plus provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC‑MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 04490754500 BARB ONLINE DAT Barbiturates Plus en 14 FF00000006ABDF0E FF00000000177F0E 04490754190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useApplication in urineBarbiturates Plus (BARB) is an in vitro diagnostic test for the qualitative and semiquantitative detection of barbiturates in human urine on cobas c systems at a cutoff concentration of 200 ng/mL. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC‑MS). Barbiturates Plus provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC‑MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.Application in serum and plasma**not available in all countriesBarbiturates Plus (BARB) is an in vitro diagnostic test for the qualitative detection of barbiturates in human serum and plasma on cobas c systems at a cutoff concentration of 200 ng/mL. The assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC‑MS) or Liquid Chromatography coupled with Tandem Mass Spectrometry (LC‑MS/MS) is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical considerations and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 1704490754190c501sp BARB ONLINE DAT Barbiturates Plus en 4 FF0000000470DA0E FF00000001D5530E 04490754190 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useBarbiturates Plus (BARB) is an in vitro diagnostic test for the qualitative detection of barbiturates in human serum and plasma on Roche/Hitachi cobas c systems at a cutoff concentration of 200 ng/mL. The assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC‑MS) or Liquid Chromatography coupled with Tandem Mass Spectrometry (LC‑MS/MS) is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 0204490754190c501 BARB ONLINE DAT Barbiturates Plus en 14 FF00000006BAAB0E FF00000006BAAB0E 04490754190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useBarbiturates Plus (BARB) is an in vitro diagnostic test for the qualitative and semiquantitative detection of barbiturates in human urine on cobas c systems at a cutoff concentration of 200 ng/mL. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC‑MS). Barbiturates Plus provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC‑MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998.Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 0208056889190c503 BARB ONLINE DAT Barbiturates Plus en 3 FF000000069DCF0E FF00000005BBA80E 08056889190 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useBarbiturates Plus (BARB) is an in vitro diagnostic test for the qualitative and semiquantitative detection of barbiturates in human urine on cobas c systems at a cutoff concentration of 200 ng/mL. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC‑MS). Barbiturates Plus provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC‑MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998.Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 08056889500 BARB ONLINE DAT Barbiturates Plus en 5 FF00000006794D0E FF0000000521080E 08056889190 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useApplication in urineBarbiturates Plus (BARB) is an in vitro diagnostic test for the qualitative and semiquantitative detection of barbiturates in human urine on cobas c systems at a cutoff concentration of 200 ng/mL. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC‑MS).Barbiturates Plus provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC‑MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.Application in serum and plasma**not available in all countriesBarbiturates Plus (BARB) is an in vitro diagnostic test for the qualitative detection of barbiturates in human serum and plasma on cobas c systems at a cutoff concentration of 200 ng/mL. The assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC‑MS) or Liquid Chromatography coupled with Tandem Mass Spectrometry (LC‑MS/MS) is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical considerations and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 0108056889190c503 BARB ONLINE DAT Barbiturates Plus en 3 FF0000000521AC0E FF0000000521AC0E 08056889190 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Barbiturates Plus (BARB) is an in vitro diagnostic test for the qualitative and semiquantitative detection of barbiturates in human urine on Roche/Hitachi cobas c systems at a cutoff concentration of 200 ng/mL. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC‑MS). Barbiturates Plus provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC‑MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998.Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 1708056889190c503sp BARB ONLINE DAT Barbiturates Plus en 3 FF0000000471040E FF000000039DC50E 08056889190 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useBarbiturates Plus (BARB) is an in vitro diagnostic test for the qualitative detection of barbiturates in human serum and plasma on Roche/Hitachi cobas c systems at a cutoff concentration of 200 ng/mL. The assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC‑MS) or Liquid Chromatography coupled with Tandem Mass Spectrometry (LC‑MS/MS) is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en